Aetna Reports Second Quarter 2005 Results



HARTFORD, Conn., July 28, 2005 — Aetna (NYSE: AET) today announced second-quarter operating earnings of $1.20 per share. Operating earnings, excluding favorable reserve development, were $1.08 per share, an increase of 27 percent compared to the prior-year quarter. Favorable reserve development was $35 million after tax, or $0.12 per share, related primarily to the resolution of matters associated with the New York State Market Stabilization Pool. The increase in operating earnings reflects a 13 percent growth in revenues from higher membership levels, strong underwriting results, and continued general and administrative expense efficiencies. Operating earnings exclude net realized capital gains and other items.1 Net income for the quarter was $1.35 per share compared to $0.90 per share in the prior-year quarter, a 50 percent increase.

"Our results this quarter demonstrate the continued, strong growth of Aetna in the marketplace," said John W. Rowe, M.D., chairman and CEO. "Operating earnings per share increased by 27 percent from the prior-year period and medical membership increased by another 60,000, bringing our total growth to nearly 780,000 so far in 2005. In addition, we continue to see solid growth in our specialty products, where we gained an additional 111,000 pharmacy members and 143,000 dental members in the quarter.

"Regarding future profitable growth, Aetna has ramped up for broader participation in Medicare, including the new Medicare Part D prescription drug plan on a national basis and Individual Medicare Advantage plan options in selected regions," Rowe said. "We now anticipate Aetna will spend approximately $50 million to prepare for these opportunities, nearly double our original plan. In addition, we expect interest rate expense will increase for the remainder of the year, due to the termination of interest rate swaps. Despite these additional expenses, we are very pleased to reaffirm our full-year EPS projection of $4.52 to $4.57."

Quarterly Financial Results at a Glance

Three Months Ended
June 30
2005
June 30
2004*
Change
 
Total revenues
$5.5 billion
$4.9 billion
13%

Operating earnings**
$362.6 million $282.6 million 28%
Net income $409.7 million $286.3 million 43%
Per share results:      
Operating earnings** $1.20 $0.89 35%
Favorable reserve development (0.12) (0.04)  
Operating earnings, excluding development** $1.08 $0.85 27%
Net income $1.35 $0.90 50%
Weighted average common shares (diluted) 303.1 million 319.9 million (5.3%)
* Prior-period results per common share have been adjusted to reflect the March 11, 2005, two-for-one stock split.

** For a full description of operating earnings and per share operating earnings, refer to footnote 1 at the end of the press release.

"With the completion of our strategic acquisitions of ActiveHealth Management and HMS Healthcare during the second quarter, we have expanded our capabilities and reach in some important markets," said Ronald A. Williams, president. "ActiveHealth provides vital evidence-based medical management and data analytics products and services to a broad range of customers, and HMS strengthens Aetna's local market presence — particularly in Michigan and Colorado — by providing access to highly competitive health care networks. With these additional resources, we are well-positioned to build upon our integrated approach to health care, with its strong focus on medical costs and quality."

Health Care business results

Health Care, which provides a full range of insured and self-insured medical, dental, pharmacy and behavioral health products and services, reported:

Group Insurance business results

Group Insurance, which includes group life, disability and long-term care products, reported:


Large Case Pensions business results

Large Case Pensions, which manages a variety of discontinued and other retirement and savings products primarily for defined benefit and defined contribution plan customers, reported:


Total Company results


A live audio webcast of the second-quarter results conference call will begin at 8:30 a.m. ET today. The public may access the conference call through a live audio webcast available on Aetna's Internet Investor Information link at www.aetna.com. Financial, statistical and other information related to the conference call, including additional GAAP reconciliations, will be available on Aetna's Investor Information site.

The conference call also can be accessed by dialing 877-502-9274, or 913-981-5584 for international callers. The Company suggests participants dial in approximately 10 minutes prior to the call. Individuals who dial in will be asked to identify themselves and their affiliations.

A replay of the call may be accessed through Aetna's Investor Information link on the Internet at www.aetna.com or by dialing 888-203-1112, or 719-457-0820 for international callers. The replay access code is 1869846. Telephone replays will be available from 11:30 a.m. ET on July 28th until midnight ET on Aug. 4.

As one of the nation's leading providers of health care, dental, pharmacy, group life, disability and long-term care benefits, Aetna puts information and helpful resources to work for its approximately 14.435 million medical members, 12.976 million dental members, 9.117 million pharmacy members and 13.662 million group insurance members to help them make better informed decisions about their health care and protect their finances against health-related risks. Aetna provides easy access to cost-effective health care through a nationwide network of more than 684,000 health care professionals, including over 405,000 primary care and specialist doctors and 4,135 hospitals. For more information, please visit www.aetna.com. (Figures as of June 30, 2005)


1 Operating earnings exclude an other item and net realized capital gains and losses from income from continuing operations, as discussed below. Although the excluded items may recur, management believes that operating earnings and operating earnings per share provide a more useful comparison of its underlying business performance from period to period. Management uses operating earnings to assess business performance and to make decisions regarding its operations and allocation of resources among its businesses. Operating earnings is also the measure reported to the Chief Executive Officer for these purposes. Each of these excluded items is discussed below:


The Company also displays certain metrics (e.g., medical cost ratios, operating earnings, operating earnings per share and pretax operating margins) excluding reserve development. Each quarter, the Company re-examines previously established health care cost payable estimates based on actual claim submissions and other changes in facts and circumstances. Decreases (increases) in prior periods' estimates represent the effect of favorable (unfavorable) development of prior-period health care cost estimates on current period results of operations, at each financial statement date. The Company believes excluding reserve development better reflects the underlying current-period health care costs.

For a reconciliation of these items to financial measures calculated under accounting principles generally accepted in the United States of America (GAAP), refer to the tables on pages 8 to 12 of this release.

2 Operating expenses as a percentage of revenue excludes net realized capital gains and losses from total revenue. Net realized capital gains and losses do not directly relate to the underwriting or servicing of products for customers and are not directly related to the core performance of the Company's business operations. For a reconciliation to operating expense as a percentage of revenue calculated under GAAP, refer to the tables on page 12 at the end of this press release.

3 In order to provide useful information regarding profitability of the Company on a basis comparable to others in the industry, without regard to financing decisions, income taxes and amortization of other acquired intangible assets (each of which may vary for reasons not directly related to performance of the underlying business), the Company's pretax operating margin excludes interest expense, income taxes and amortization of other acquired intangible assets. Management also uses pretax operating margin to assess its performance, including performance versus competitors. Operating earnings used in the pretax margin calculation also exclude the items noted in footnote 1. For a reconciliation to operating margin calculated under GAAP, refer to the tables on page 12 of this release.


ADDITIONAL INFORMATION; CAUTIONARY STATEMENT -- Certain information in this press release is forward looking, including our projection as to earnings. Forward-looking information is based on management's estimates, assumptions and projections, and is subject to significant uncertainties and other factors, many of which are beyond Aetna's control. Important risk factors could cause actual future results and other future events to differ materially from those currently estimated by management. Those risk factors include, but are not limited to: unanticipated increases in medical costs (including increased medical utilization, increased pharmacy costs, increases resulting from unfavorable changes in contracting or re-contracting with providers, changes in membership mix to lower-premium or higher-cost products or membership-adverse selection; as well as changes in medical cost estimates due to the necessary extensive judgment that is used in the medical cost estimation process, the considerable variability inherent in such estimates, and the sensitivity of such estimates to changes in medical claims payment patterns and changes in medical cost trends); decreases in membership or failure to achieve desired membership growth due to significant competition or other factors; increases in medical costs or Group Insurance claims resulting from any acts of terrorism or otherwise; the ability to reduce administrative expenses while maintaining targeted levels of service and operating performance, and to improve relations with providers while taking actions to reduce medical costs; the ability to successfully implement Aetna's operating model to a projected growing membership base and to successfully implement multiple strategic and operational initiatives simultaneously; lower levels of investment income from continued low interest rates; adverse government regulation (including legislative proposals eliminating or reducing ERISA pre-emption of state laws that would increase potential litigation exposure, and other proposals, such as patients' rights legislation, that would increase potential litigation exposure or mandate coverage of certain health benefits); adverse pricing actions by government payors; changes in size, product mix and medical cost experience of membership in key markets; our ability to integrate, simplify, and enhance our existing information technology system and platform to keep pace with changing customer and regulatory needs; and the outcome of various litigation and regulatory matters, including litigation and ongoing reviews of business practices by various regulatory authorities (including the current industry wide investigation into insurance brokerage practices concerning broker compensation arrangements, bid quoting practices and potential antitrust violations being conducted by the New York Attorney General, the Connecticut Attorney General, and others, and for which the Company has received and may receive subpoenas, and may be subject to related litigation). For more discussion of important risk factors that may materially affect Aetna, please see the risk factors contained in Aetna's 2004 Annual Report on Form 10-K, on file with the Securities and Exchange Commission. You also should read Aetna's 2004 Annual Report on Form 10-K and Aetna's 2005 second quarter report on Form 10-Q when filed with the Securities and Exchange Commission for a discussion of Aetna's historical results of operations and financial condition.




Related Links:

2Q05 Financial Supplement
(PDF: 965 KB / 16 pages)

2Q05 Earnings Tables
(PDF: 24 KB / 5 pages)

Guidance Summary
7/28/05

(PDF: 158 KB / 3 pages)




Copyright Aetna Inc.